Send the following on WhatsApp
Continue to Chat多發性骨髓瘤療法再加一!楊森旗下療法雙特異性抗體 Tecvayli 獲美 FDA 核准 https://geneonline.news/janssen-tecvayli-fda-approved/?variant=zh-cn
多發性骨髓瘤療法再加一!楊森旗下療法雙特異性抗體 Tecvayli 獲美 FDA 核准 https://geneonline.news/janssen-tecvayli-fda-approved/?variant=zh-cn